Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / #OTHER
-
Shares outstanding
-
67M
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
54.9M
-
Shares change
-
-806K
-
Total reported value, excl. options
-
$388M
-
Value change
-
-$38.1M
-
Put/Call ratio
-
0.91
-
Number of buys
-
49
-
Number of sells
-
-36
-
Price
-
$7.08
Significant Holders of Generation Bio Co. - #OTHER (GBIO) as of Q4 2021
101 filings reported holding GBIO - Generation Bio Co. - #OTHER as of Q4 2021.
Generation Bio Co. - #OTHER (GBIO) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 54.9M shares
of 67M outstanding shares and own 81.87% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (8.65M shares), FMR LLC (8.54M shares), Atlas Venture Life Science Advisors, LLC (8.28M shares), Bellevue Group AG (3.87M shares), VANGUARD GROUP INC (3.59M shares), FARALLON CAPITAL MANAGEMENT LLC (3.5M shares), BlackRock Inc. (3.17M shares), Artal Group S.A. (2.81M shares), Yiheng Capital Management, L.P. (1.98M shares), and STATE STREET CORP (1.95M shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.